TapImmune to Present at the 2017 BioFlorida Conference


TapImmune in St. Petersburg, FL for 20th Bioflorida Conference

[/vc_column_text][vc_empty_space height=”8px”][vc_column_text]Jacksonville, Florida, October 12, 2017 / TapImmune Inc. (NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing  clinical trials in ovarian and breast cancer, today announced that representatives of the Company will be featured in two panel discussions at the 2017 BioFlorida Conference, held October 15-17, at The Vinoy Renaissance St. Petersburg Resort and Golf Club.  The Company will be featured in the BioBusiness Session on Monday, October 16th, and in the BioTrends Session on Tuesday, October 17th, and will participate in one-on-one meetings with potential strategic collaboration partners.

[/vc_column_text][vc_empty_space height=”25px”][vc_column_text]About BioFlorida

BioFlorida is the voice of Florida’s life sciences industry, representing nearly 6,000 establishments and research organizations in the biopharmaceutical, medical technology and bioagriculture sectors that collectively employ nearly 83,000 Floridians.[/vc_column_text][vc_column_text][pr-disclaimer]